Company intelligence / Profile preview

BioSyent Pharma

Mississauga, Ontario, Canada

Ownership: Private
Employees: ~50
Development stage: Other

Overview

BioSyent commercializes specialty pharmaceutical products in Canada and select international markets, with marketed brands across iron deficiency, women's health, pain, and supportive care. The company's products are mainly established therapies either launched or in late-stage growth, with ongoing portfolio expansion targeting identified market gaps. No novel clinical-stage NMEs, but new formulations and in-licensing/registration efforts are ongoing[10][11].

Therapeutic areas: EndocrinologyWomen's HealthGastroenterologyNeurologyHematologyOther
Modalities: Small moleculeBiologicDevice
Industry: Biotech

Beyond the preview

Go deeper on BioSyent Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSyent Pharma.

Explore the full profile